Heterogeneity of risk for melanoma and pancreatic and digestive malignancies
Open Access
- 4 November 2004
- Vol. 101 (12) , 2809-2816
Abstract
BACKGROUND: Data addressing the interfamilial heterogeneity of melanoma are limited. In the current study, the authors assessed melanoma risk according to family history of melanoma and other melanoma‐associated malignancies and evaluated the familial heterogeneity of melanomas, pancreatic malignancies, and gastrointestinal malignancies.METHODS: The authors obtained patient histories of malignancy in first‐degree relatives as part of a clinic‐based case–control study. The case group included 737 newly diagnosed patients with invasive melanoma, and the control group included 1021 outpatients from clinics at the same medical centers. To assess heterogeneity of risk among families affected by melanoma, a nonparametric method was used to detect extrabinomial variation. In addition, selected patients with melanoma (n = 133) were tested for germline mutations in CDKN2A.RESULTS: The adjusted odds ratio associated with a family history of melanoma was 1.7 (95% confidence interval, 1.1–2.7). Family histories of pancreatic, gastrointestinal, brain, breast, or lymphoproliferative disease did not increase the risk of melanoma significantly. Among case families, significant evidence of familial heterogeneity was found for melanomas, but not for pancreatic or gastrointestinal malignancies. Two mutations in CDKN2A previously associated with melanoma risk were identified among the 133 patients tested in the case group; mutation detection did not differ between families with low and high heterogeneity scores.CONCLUSIONS: Familial heterogeneity testing in the study population did not improve the selection of high‐risk families for genetic study. Even in a large case–control study, few families that had multiple members with melanoma were identified, and family members with pancreatic malignancies were rare. Cancer 2004. Published 2004 by the American Cancer Society.Keywords
This publication has 31 references indexed in Scilit:
- Geographical Variation in the Penetrance of CDKN2A Mutations for MelanomaJNCI: Journal of the National Cancer Institute, 2002
- Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone familiesCancer, 2001
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Validation of Family History of Cancer in Deceased Family MembersJNCI: Journal of the National Cancer Institute, 1996
- Germline mutations in the p16INK4a binding domain of CDK4 in familial melanomaNature Genetics, 1996
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsNew England Journal of Medicine, 1995
- Risk of cutaneous melanoma associated with a family history of the diseaseInternational Journal of Cancer, 1995
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- A nonparametric test of heterogeneity of family riskGenetic Epidemiology, 1986